Clinical Trial Update: Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

View source ↗

Summary

A multicenter study is evaluating reduced-dose chemotherapy followed by 14 days of blinatumomab for newly diagnosed adult B-lymphoblastic leukemia; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Shandong University | Conditions: Leukemia, Lymphocytic, Acute, Adult | Status: NOT_YET_RECRUITING